Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31079405 | 0.78 | THRB (0.40) | THRBLMNA | |
| SCHEMBL5666168 | 0.76 | THRB (0.50) | THRBLMNA | |
| SCHEMBL8588639 | 0.76 | THRB (0.38) | THRBLMNA | |
| SCHEMBL1701153 | 0.76 | ALDH1A1 (0.39) | THRBLMNA | |
| SCHEMBL18042684 | 0.74 | THRB (0.36) | THRBLMNA | |
| SCHEMBL3103579 | 0.74 | ADRB2 (0.38) | THRBLMNA | |
| SCHEMBL3384164 | 0.72 | THRB (0.40) | THRBLMNA | |
| SCHEMBL20597785 | 0.72 | USP2 (0.46) | THRBLMNA | |
| SCHEMBL7753817 | 0.71 | THRB (0.44) | THRBLMNA | |
| SCHEMBL25722 | 0.71 | THRB (0.44) | THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150238623-A1 | Dendrimers, Conjugates and Methods Thereof | CENTRE FOR BIOSEPARATION TECHNOLOGY-VIT (IN) | 2015-08-27 | — | — | US | claimed |
| WO-2014041517-A2 | DENDRIMERS, CONJUGATES AND METHODS THEREOF | CENTRE FOR BIOSEPARATION TECHNOLOGY-VIT (IN) | 2014-03-20 | — | — | WO | claimed |
| US-9700632-B2 | Dendrimers, conjugates and methods thereof | CENTRE FOR BIOSEPERATION TECHNOLOGY-VIT (IN) | 2017-07-11 | — | — | US | disclosed |
| US-20150238623-A1 | Dendrimers, Conjugates and Methods Thereof | CENTRE FOR BIOSEPARATION TECHNOLOGY-VIT (IN) | 2015-08-27 | — | — | US | disclosed |
| WO-2014041517-A2 | DENDRIMERS, CONJUGATES AND METHODS THEREOF | CENTRE FOR BIOSEPARATION TECHNOLOGY-VIT (IN) | 2014-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150238623-A1 | Dendrimers, Conjugates and Methods Thereof | PAICS, CD2BP2, CD44 | THRB 1684/4885LMNA 3059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.